Accéder au contenu
Merck
  • Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates.

Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates.

Antimicrobial agents and chemotherapy (2005-09-29)
Mark A Webber, Ashraf Talukder, Laura J V Piddock
RÉSUMÉ

Fluoroquinolone-resistant Escherichia coli isolates which overexpressed acrB and had a substitution at amino acid 45 of AcrR were complemented with wild-type acrR. Complementation led to increased sensitivity to ciprofloxacin and to ethidium bromide, suggesting that mutation at amino acid 45 of AcrR contributes to ciprofloxacin resistance.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Human IgG Fc Control Protein, recombinant protein